Abeona Therapeutics (FRA:PCJ) 3-Year Revenue Growth Rate : -60.70% (As of Dec. 2023)

View and export this data going back to 1980. Start your Free Trial

What is Abeona Therapeutics 3-Year Revenue Growth Rate?

Abeona Therapeutics's Revenue per Share for the three months ended in Dec. 2023 was €0.00.

During the past 12 months, Abeona Therapeutics's average Revenue per Share Growth Rate was -8.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -60.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Abeona Therapeutics was 236.90% per year. The lowest was -84.00% per year. And the median was 21.80% per year.

Competitive Comparison of Abeona Therapeutics's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Abeona Therapeutics's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abeona Therapeutics's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abeona Therapeutics's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Abeona Therapeutics's 3-Year Revenue Growth Rate falls into.

Abeona Therapeutics 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Abeona Therapeutics (FRA:PCJ) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Abeona Therapeutics 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Abeona Therapeutics's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Abeona Therapeutics (FRA:PCJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abeona Therapeutics Inc (FRA:PCJ) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

ABEO:USA

Address

1330 Avenue of the Americas, 33rd Floor, New York, NY, USA, 10019

Website

https://www.abeonatherapeutics.com

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B.

Abeona Therapeutics (FRA:PCJ) Headlines

No Headlines